BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report) announced a quarterly dividend on Friday, August 7th. Investors of record on Monday, August 17th will be given a dividend of 0.1415 per share on Friday, September 4th. This represents a c) dividend on an annualized basis and a yield of 6.0%. The ex-dividend date is Monday, August 17th.
BR Biopharma Trading Up 0.5%
Shares of NASDAQ:BRBI opened at $9.40 on Friday. The company’s fifty day moving average is $11.32. BR Biopharma has a 1-year low of $9.23 and a 1-year high of $67.01.
BR Biopharma (NASDAQ:BRBI – Get Free Report) last posted its earnings results on Tuesday, June 30th. The company reported $0.09 earnings per share (EPS) for the quarter. The firm had revenue of $25.13 million during the quarter.
About BR Biopharma
BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.
Recommended Stories
- Five stocks we like better than BR Biopharma
- AirJoule Technologies: Short Squeeze Setup Amid Rising Risks
- MarketBeat Week in Review – 08/10 – 08/14
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
Receive News & Ratings for BR Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BR Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
